Biotechnology Equity Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology equity research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Equity Research Today - Breaking & Trending Today

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA

Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Tamil Nadu , Santhosh Palani , Laras Sullivan , Pamela Connealy , University Of Pennsylvania , Principal At New Enterprise Associates , Exchange Commission , Biotechnology Equity Research At Cowen , Pfizer Inc , Health Sciences , Columbia University , Pyxis Oncology Inc , Takeda Pharmaceuticals , Texasam University , University Of Madras , Oncology Expands Board , Pyxis Oncology , Chief Executive Officer , New Enterprise Associates , Vice President , Biotechnology Equity Research , Private Securities Litigation Reform Act , Annual Report , Quarterly Report ,

IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted. ....

Anupam Rama , Andres Ruiz Briseno , Yujiros Hata , Exchange Commission , Werner Helicase Inhibitor Development , Biosciences Inc , Biotechnology Equity Research , Healthcare Conference , Chief Executive Officer , Managing Director , Equity Research , Pol Theta Helicase , Werner Helicase Inhibitor Development Candidate , Investor Relations , Quarterly Report , Vice President , Ideaya Biosciences ,

IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance

SOUTH SAN FRANCISCO, Calif., Jan. 7, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 corporate guidance and program updates. 42nd Annual J.P. Morgan Healthcare ConferenceTuesday, January 9th, 2024 […] ....

Yujiros Hata , Anupam Rama , Andres Ruiz Briseno , Werner Helicase Inhibitor Development , Biosciences Inc , Biotechnology Equity Research , Exchange Commission , Healthcare Conference , Chief Executive Officer , Managing Director , Equity Research , Pol Theta Helicase , Werner Helicase Inhibitor Development Candidate , Investor Relations , Quarterly Report , Vice President ,

Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 3, 2024 /PRNewswire/ Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the 42th. ....

United States , San Francisco , Ali Chartan , Deric Joseph , Johnc Jacobs , Erika Schultz , Francis Hotel , Novavax Inc , Biotechnology Equity Research , Standard Time , Executive Director , Biotechnology Equity , Chief Executive ,

Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief. ....

United States , Kristen Kluska , Brianm Culley , Biotechnology Equity Research , Lineage Cell Therapeutics Inc , Roche Group , Intercontinental New York Barclay Hotel , Cantor Fitzgerald Co , Cantor Fitzgerald , Lineage Cell Therapeutics , Chief Executive Officer , Healthcare Conference , Managing Director , Intercontinental New York Barclay , Cell Therapeutics ,